Stephen Fowler Flatt - 22 Aug 2025 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
CEO, Director
Signature
/s/ Stephen Flatt
Issuer symbol
NHC
Transactions as of
22 Aug 2025
Net transactions value
-$65,144
Form type
4
Filing time
26 Aug 2025, 16:20:37 UTC
Previous filing
30 Jun 2025
Next filing
13 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Flatt Stephen Fowler CEO, Director 100 VINE STREET, MURFREESBORO /s/ Stephen Flatt 26 Aug 2025 0001330766

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Common Stock Options Exercise $107,880 +2,000 +3.4% $53.94 60,756 22 Aug 2025 Direct F1
transaction NHC Common Stock Tax liability $156,500 -1,363 -2.2% $114.82 59,393 22 Aug 2025 Direct F2
transaction NHC Common Stock Options Exercise $188,200 +2,000 +3.4% $94.10 61,393 22 Aug 2025 Direct F3
transaction NHC Common Stock Tax liability $204,724 -1,783 -2.9% $114.82 59,610 22 Aug 2025 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Options Exercise $0 -2,000 -20% $0.000000 8,000 22 Aug 2025 Common Stock 10,000 $53.94 Direct F1
transaction NHC Option to Purchase Common Stock Options Exercise $0 -2,000 -13% $0.000000 13,000 22 Aug 2025 Common Stock 15,000 $94.10 Direct F3
holding NHC Option to Purchase Common Stock 18,000 22 Aug 2025 Common Stock 18,000 $90.62 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 Shares were withheld by the Company to pay the exercise price and withholding tax obligations.
F3 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F4 Total amount of shares beneficially owned following transactions reported on this form.